When barriers fail: the role of endothelial dysfunction in rare pediatric neuromuscular diseases

Aleksandra Agafonova1, Alessia Cosentino2, Chiara Prinzi2

  • 1Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

Frontiers in Medicine
|August 4, 2026
PubMed

Insights

Endothelial dysfunction and blood-nerve barrier alterations are implicated in rare pediatric neuromuscular diseases. Further research is needed to understand these mechanisms for better diagnosis and treatment.

Area of Science:

  • Neurology
  • Vascular Biology
  • Pediatrics

Background:

  • Rare pediatric neuromuscular diseases involve heterogeneous disorders.
  • Endothelial dysfunction and blood-tissue barrier alterations contribute to disease progression.
  • The blood-nerve barrier (BNB) is crucial for nerve function and integrity.

Purpose of the Study:

  • To review current knowledge on endothelial and barrier alterations in rare pediatric neuromuscular diseases.
  • To highlight the role of the blood-brain barrier (BBB) and BNB in disease pathophysiology.
  • To identify potential diagnostic and therapeutic targets.

Main Methods:

  • Literature review of studies on endothelial and barrier function in rare pediatric neuromuscular diseases.
  • Analysis of evidence from conditions like Duchenne muscular dystrophy (DMD), spinal muscular atrophy (SMA), Kawasaki Disease (KD), CIDP, and AIDP.
  • Focus on the structural and functional similarities and differences between BBB and BNB.

Main Results:

  • Endothelial dysfunction and barrier alterations are observed in various rare pediatric neuromuscular diseases.
  • Abnormalities in BBB and BNB integrity can lead to inadequate perfusion and neuroinflammation.
  • BNB endothelial cells exhibit unique restrictive properties due to higher junctional protein density.

Conclusions:

  • Vascular and barrier abnormalities significantly influence disease severity in rare pediatric neuromuscular disorders.
  • The precise mechanisms of BNB disruption require further elucidation for several conditions.
  • Understanding these processes is vital for developing targeted diagnostic and therapeutic strategies.

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview